Ensuring compatibility between an active pharmaceutical ingredient (API) and its excipients is a critical facet of drug development, influencing stability, efficacy and safety of the final dosage form ...

A new pilot program from the US Food and Drug Administration (FDA) dedicated to reviewing quality and toxicology data for novel drug excipients is aimed at speeding drug development by providing an ...

Pharmaceutical companies follow strict quality standards, and if a drug’s stability falters at any point – whether during development, storage, or shipping, it can undo all the work that’s gone into ...